Brian Tse, Ph.D., and Erik Wolf, Ph.D.


WASHINGTON, September 20, 2021 / PRNewswire / – Brian joins The Conafay Group after eleven years with the Biomedical Advanced Research & Development Authority (BARDA), while Erik joins the team after six years with the US Army Medical Research and Development Command (USAMRDC) in Fort Detrick.

Brian brings extensive experience in the development of medical products, with a focus on advancing technologies to strengthen national health security. His experiences in BARDA’s CBRN division span a variety of product types (drugs, biologics, devices, diagnostics), biomedical threat areas, and federal government-private sector partnership models. Brian got his doctorate. in Organic Chemistry from Harvard University. He graduated Phi Beta Kappa from the University of Buffalo, where he obtained a BS in Chemistry / Medicinal Chemistry.

Erik brings extensive experience in military medical research and development, having managed R&D in musculoskeletal injuries and medical simulation and information science, as well as an integrator of the science and technology portfolio of the senior research and technology assistant at USAMRDC. Prior to joining USAMRDC, Erik served as the Senior Research Biomedical Engineer for the Center of Excellence in Trauma and Limb Amputation at Walter Reed National Military Medical Center. He obtained his bachelor’s, master’s and doctoral degrees in biomedical engineering at the University of Pittsburgh.

The Conafay Group (TCG), founded by a DC veteran Stephen R. Conafay in 2012, is a federal government affairs consulting firm combining traditional government relations with a particular focus on non-dilutive financing for the healthcare industry. We serve organizations in the field of life sciences and human health, such as biopharmaceutical and medical device companies, academic and research institutions and coalitions. Our team of over a dozen people bring experience from Capitol Hill, government agencies and the pharmaceutical industry. More information on:


Related links


Comments are closed.